463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797634008387944448 |
|---|---|
| author | Tong Hu Milan Chheda Albert Kim Ashwani Kesarwani Amanda De Andrade Costa Jeremy N Rich Pei-Yong Shi Michael S Diamond |
| author_facet | Tong Hu Milan Chheda Albert Kim Ashwani Kesarwani Amanda De Andrade Costa Jeremy N Rich Pei-Yong Shi Michael S Diamond |
| author_sort | Tong Hu |
| collection | DOAJ |
| first_indexed | 2024-03-11T12:01:46Z |
| format | Article |
| id | doaj.art-82f29ec4745947e69a37e43090e8f89c |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T12:01:46Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-82f29ec4745947e69a37e43090e8f89c2023-11-08T01:15:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0463463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapyTong Hu0Milan Chheda1Albert Kim2Ashwani Kesarwani3Amanda De Andrade Costa4Jeremy N Rich5Pei-Yong Shi6Michael S Diamond71Washington University School of Medicine, Saint Louis, MO, USA1Washington University School of Medicine, Saint Louis, MO, USA1Washington University in Saint Louis, St. Louis, MO, USA1Washington University in St. Louis, St. Louis, MO, USA1Washington University in St. Louis, St. Louis, MO, USA2University of Pittsburgh, Pittsburgh, PA, USA3University of Texas, Texas, TX, USA1Washington University in St. Louis, St. Louis, MO, USA |
| spellingShingle | Tong Hu Milan Chheda Albert Kim Ashwani Kesarwani Amanda De Andrade Costa Jeremy N Rich Pei-Yong Shi Michael S Diamond 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy Journal for ImmunoTherapy of Cancer |
| title | 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy |
| title_full | 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy |
| title_fullStr | 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy |
| title_full_unstemmed | 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy |
| title_short | 463 Targeting a novel myeloid checkpoint Siglec-15 in GBM generates an extremely durable response with Zika virus oncolytic therapy |
| title_sort | 463 targeting a novel myeloid checkpoint siglec 15 in gbm generates an extremely durable response with zika virus oncolytic therapy |
| work_keys_str_mv | AT tonghu 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT milanchheda 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT albertkim 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT ashwanikesarwani 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT amandadeandradecosta 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT jeremynrich 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT peiyongshi 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy AT michaelsdiamond 463targetinganovelmyeloidcheckpointsiglec15ingbmgeneratesanextremelydurableresponsewithzikavirusoncolytictherapy |